MINI FUTURE SHORT - BECTON DICKINSON AND CO. Share Price

Certificat

DE000ME7S461

Real-time Bid/Ask 09:47:37 03/06/2024 pm IST
2.88 EUR / 2.93 EUR -16.52% Intraday chart for MINI FUTURE SHORT - BECTON DICKINSON AND CO.
1 month+9.09%
3 months+13.36%
Date Price Change
03/24/03 3.37 -3.16%
31/24/31 3.48 -11.22%
30/24/30 3.92 -2.49%
29/24/29 4.02 +4.15%
28/24/28 3.86 +8.12%

Delayed Quote Börse Stuttgart

Last update June 03, 2024 at 04:11 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7S46
ISINDE000ME7S461
Date issued 29/01/2024
Strike 268.6 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.97
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.02
Lowest since issue 1.93
Spread 0.05
Spread %1.76%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus